1. Home
  2. OABI vs BNR Comparison

OABI vs BNR Comparison

Compare OABI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$1.86

Market Cap

253.4M

Sector

Health Care

ML Signal

N/A

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$23.57

Market Cap

252.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OABI
BNR
Founded
2012
2014
Country
United States
China
Employees
114
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.4M
252.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OABI
BNR
Price
$1.86
$23.57
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.67
N/A
AVG Volume (30 Days)
279.2K
13.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$74.84
$136.32
Revenue Next Year
$40.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$2.18
52 Week High
$3.33
$41.72

Technical Indicators

Market Signals
Indicator
OABI
BNR
Relative Strength Index (RSI) 51.31 41.16
Support Level $1.68 $19.72
Resistance Level $1.89 $24.23
Average True Range (ATR) 0.11 1.74
MACD 0.02 -0.27
Stochastic Oscillator 46.15 31.10

Price Performance

Historical Comparison
OABI
BNR

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: